Related Experiment Video
Updated: Apr 14, 2026

06:42
Subtype-selective Electroporation of Cortical Interneurons
Published on: August 18, 2014
9.3K
Local co-expression of GLP1R and INS in human cortical interneurons
Nóra Faragó1,2, Katalin Á Kocsis1, Sándor Bordé1
1HUN-REN-SZTE Research Group for Cortical Microcircuits, Department of Physiology, Anatomy and Neuroscience, University of Szeged, Szeged, Hungary.
Frontiers in Endocrinology
|April 13, 2026
Summary
Human cortical neurogliaform and rosehip interneurons express glucagon-like peptide-1 receptor (GLP1R) and insulin (INS). This suggests a local signaling loop within the brain, potentially impacting neurodegenerative conditions.
Area of Science:
- Neuroscience
- Molecular Biology
- Metabolic Regulation
Background:
- Glucagon-like peptide-1 receptor (GLP1R) and insulin (INS) are key in peripheral metabolism.
- Emerging evidence indicates central nervous system roles for GLP1R and INS.
- Understanding their intracortical functions is crucial for brain health.
Purpose of the Study:
- To investigate the expression of GLP1R and INS in specific human cortical interneuron subtypes.
- To explore the potential for local intracortical metabolic signaling pathways.
Main Methods:
- Laser capture microdissection of human cortical layer 1 GABAergic interneurons.
- Transcriptomic subtyping using digital PCR for LAMP5, SV2C, and PRSS12 markers.
- Quantification of GLP1R and INS mRNA using single-cell digital PCR and spatial validation with RNAscope Hi-Plex in situ hybridization.
Main Results:
- Neurogliaform and rosehip cells showed significantly higher GLP1R and INS expression compared to other LAMP5 interneurons.
- GLP1R mRNA was detected in 44/72 neurogliaform and 18/36 rosehip cells.
- INS mRNA was detected in 29/72 neurogliaform and 11/36 rosehip cells, with non-random co-expression.
Conclusions:
- Human cortical neurogliaform and rosehip interneurons selectively co-express GLP1R and INS.
- This co-expression supports the existence of a local intracortical GLP1R-insulin signaling loop.
- Findings offer insights into cerebral glucose regulation and neurodegenerative diseases like mild cognitive impairment in diabetes mellitus.
Keywords:
GLP1RINShuman cortical interneuronsmRNAneurogliaform cellrosehip cellsingle cell mRNA sequencingMore Related Videos
Related Concept Videos
Glucagon-like Receptor Agonists
1.4K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.4K
Insulin Secretory Vesicles
7.6K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.6K

